| __timestamp | Amicus Therapeutics, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 79838000 |
| Thursday, January 1, 2015 | 76943000 | 121816000 |
| Friday, January 1, 2016 | 104793000 | 117633000 |
| Sunday, January 1, 2017 | 149310000 | 117456000 |
| Monday, January 1, 2018 | 270902000 | 171984000 |
| Tuesday, January 1, 2019 | 286378000 | 257452000 |
| Wednesday, January 1, 2020 | 308443000 | 477643000 |
| Friday, January 1, 2021 | 272049000 | 540684000 |
| Saturday, January 1, 2022 | 276677000 | 651496000 |
| Sunday, January 1, 2023 | 152381000 | 666563000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, PTC Therapeutics, Inc. and Amicus Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical breakthroughs.
From 2014 to 2023, PTC Therapeutics has consistently increased its R&D budget, peaking in 2023 with a 735% increase from its 2014 expenditure. This upward trend underscores the company's strategic focus on expanding its therapeutic pipeline.
Amicus Therapeutics has also shown a robust commitment to R&D, with a 220% increase in spending over the same period. Despite a slight dip in 2023, the company's overall trend highlights its sustained investment in developing innovative treatments.
These trends not only highlight the companies' growth trajectories but also their pivotal roles in shaping the future of biotechnology.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and PTC Therapeutics, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Amicus Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Amicus Therapeutics, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs Geron Corporation
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Galapagos NV